Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease

Published:2021-07-05 Issue:11 Volume:89 Page:1425-1441
ISSN:0887-3585
Container-title:Proteins: Structure, Function, and Bioinformatics
language:en
Short-container-title:Proteins

Author:

Yuce Merve¹^ORCID,Cicek Erdem²^ORCID,Inan Tugce¹^ORCID,Dag Aslihan Basak³,Kurkcuoglu Ozge¹^ORCID,Sungur Fethiye Aylin²^ORCID

Affiliation:

1. Department of Chemical Engineering Istanbul Technical University Istanbul Turkey

2. Computational Science and Engineering Division Informatics Institute, Istanbul Technical University Istanbul Turkey

3. Department of Molecular Biology and Genetics Istanbul Technical University Istanbul Turkey

Publisher

Wiley

Subject

Molecular Biology,Biochemistry,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prot.26164

Reference108 articles.

1. Coronaviruses — drug discovery and therapeutic options

2. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection

3. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

4. A Novel Coronavirus from Patients with Pneumonia in China, 2019

5. WHO declares COVID‐19 a pandemic;Cucinotta D;Acta Biomed,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation;ACS Omega;2024-09-13

2. A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis;Frontiers in Molecular Biosciences;2024-09-06

3. A computational workflow to determine drug candidates alternative to aminoglycosides targeting the decoding center of E. coli ribosome;Journal of Molecular Graphics and Modelling;2024-09

4. Use of hybrid molecular simulation techniques for systematic analysis of polyphenols as promising therapeutic agent against SARS-CoV-2;Journal of Molecular Structure;2024-06

5. Unlocking Therapeutic Potential: Identifying Small Molecule Inhibitors for Sars-Cov-2 Variants' Main Protease (MPRO) Through Molecular Docking Analysis;Sains Malaysiana;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3